Select region
Submit

Subscribe to our news feed

구독

A question?

2024-10-18
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

“The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased by 3.5%, of which the organic increase was 0.2%, while the operating margin weakened compared with last year.

2024-10-09
FleetView by Getinge elevates service with connected devices

Building on over 15 years of experience in connected devices, Getinge now introduces FleetView. This web application represents the next step in data-driven device lifecyle management, offering healthcare providers and life science companies a tool to navigate large amounts of service data and statistical insights. Providing a vehicle to access the insights needed to optimize operational efficiency, FleetView is not only positioned to help customers reduce total cost of ownership but also helps enhance service reliability and uptime.  

2024-10-04
Getinge invites fund managers, analysts, and media to Q3 Report 2024 conference call

Getinge will issue its Q3 Report 2024 on October 18, 2024, at 08:00 a.m. CEST, followed by a conference call at 10.00-11.00 a.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

2024-09-25
Getinge’s CE certificate for ECLS consumables reinstated

The notified body, TÜV SÜD, reinstates Getinge’s CE certificate for HLS and PLS consumables, used for ECLS therapy, with certain conditions. Temporary challenges with a supplier and production changeover related to the new packaging solution have resulted in a lower volume of HLS and PLS sets available for shipment in Q3 2024, which is expected to be phased into Q4 2024.

2024-09-11
Getinge completes the acquisition of Paragonix Technologies

Getinge has today completed the previously announced acquisition of 100% of the shares of Paragonix Technologies, Inc.

2024-09-01
Getinge makes a provision of MBRL 240 related to Brazilian investigation

Getinge makes a provision of MBRL 240, corresponding to approximately MSEK 480, related to the previously announced negotiations with the Brazilian Comptroller General of the Union (CGU) involving violations of the Brazilian Clean Companies Act.

Press Contacts

Lars Mattsson

Interim EVP Brand & Communication
Phone: +46 10 335 0043

Caroline Örmgård

Head of Public & Media Relations
Phone: +46 10 335 0041

Newsroom2

Contact us online

Click below to fill in the appropriate form. We will be in touch shortly.

Are you looking for

Getinge Hybrid OR

Image Gallery

Diverse picture format made available for press article purpose 

Man and woman looking a something together

About us

All you need to know about Getinge a one glance

Cardiosave

Urgent Medical Device Correction

Voluntary Urgent Medical Device Field Correction for the CARDIOSAVE intra-aortic balloon pump (IABP)

Newsroom

Don't miss anything

Click on the icons and follow us!